VNRX logo

VolitionRx Limited (VNRX) Cash From Financing

Annual CFF

$28.98 M
+$22.04 M+317.74%

December 31, 2023

Summary

Performance

1-Year Change

+317.74%

3-Year Change

+40.55%

5-Year Change

+61.31%

15-Year Change

+1373.45%

VNRX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.02%
VNRX annual cash flow from financing activities is higher than 72.02% of companies in Healthcare sector

High & Low

All-time High

$28.98 M
VNRX annual cash flow from financing activities is currently at an all-time high

3-Year Low

$6.94 M
VNRX annual cash flow from financing activities is currently +317.74% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VNRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
VNRX next annual earnings announcement is scheduled for Mar 26, 2025

OtherVNRXcash flowmetrics:

Annual CFI

-$1.08 M
VNRX annual cash flow from investing activities is -$1.08 million

Annual CFO

-$18.06 M
VNRX annual cash flow from operations is -$18.06 million

Annual FCF

-$19.15 M
VNRX annual free cash flow is -$19.15 million

Annual CAPEX

$1.08 M
VNRX annual capital expenditures is $1.08 million

Quarterly CFF

$5.60 M
+$4.63 M+475.64%

September 30, 2024

Summary

Performance

3-Month Change

+475.64%

1-Year Change

+48.61%

3-Year Change

+10973.72%

5-Year Change

+21.77%

VNRX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.35%
VNRX quarterly cash flow from financing activities is higher than 81.35% of companies in Healthcare sector

High & Low

All-time High

$20.21 M
VNRX quarterly cash flow from financing activities is currently -72.27% below its historical high of $20.21 million

3-Year Low

-$460.20 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXcash flowmetrics:

Quarterly CFI

-$136.70 K
VNRX quarterly cash flow from investing activities is -$136.70 thousand

Quarterly CFO

-$5.39 M
VNRX quarterly cash flow from operations is -$5.39 million

Quarterly FCF

-$5.52 M
VNRX quarterly free cash flow is -$5.52 million

Quarterly CAPEX

$136.70 K
VNRX quarterly capital expenditures is $136.70 thousand

TTM CFF

$10.14 M
+$5.88 M+137.99%

September 30, 2024

Summary

Performance

3-Month Change

+137.99%

1-Year Change

-65.02%

3-Year Change

-55.73%

5-Year Change

-46.69%

VNRX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.59%
VNRX TTM cash flow from financing activities is higher than 53.59% of companies in Healthcare sector

High & Low

All-time High

$41.03 M
VNRX TTM cash flow from financing activities is currently -75.29% below its historical high of $41.03 million

3-Year Low

$1.43 M
VNRX TTM cash flow from financing activities is currently +607.26% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXcash flowmetrics:

TTM CFI

-$684.60 K
VNRX TTM cash flow from investing activities is -$684.60 thousand

TTM CFO

-$14.01 M
VNRX TTM cash flow from operations is -$14.01 million

TTM FCF

-$14.70 M
VNRX TTM free cash flow is -$14.70 million

TTM CAPEX

$684.60 K
VNRX TTM capital expenditures is $684.60 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VNRX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+317.7%+48.6%-65.0%
3 y3 years+40.5%+10000.0%-55.7%
5 y5 years+61.3%+21.8%-46.7%

VNRX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+317.7%-67.7%+1317.6%-69.4%+607.3%
5 y5-yearat high+317.7%-72.3%+1317.6%-75.3%+607.3%
alltimeall timeat high-100.0%-72.3%+1317.6%-75.3%-100.0%

VolitionRx Limited Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$5.60 M(+475.6%)
$10.14 M(+138.0%)
Jun 2024
-
$973.40 K(-564.9%)
$4.26 M(-79.3%)
Mar 2024
-
-$209.40 K(-105.6%)
$20.63 M(-28.8%)
Dec 2023
$28.98 M(+317.7%)
$3.77 M(-1472.1%)
$28.98 M(+10.9%)
Sep 2023
-
-$274.80 K(-101.6%)
$26.14 M(-21.1%)
Jun 2023
-
$17.34 M(+112.8%)
$33.14 M(+116.0%)
Mar 2023
-
$8.15 M(+779.8%)
$15.34 M(+121.1%)
Dec 2022
$6.94 M(-69.6%)
$926.00 K(-86.2%)
$6.94 M(-14.4%)
Sep 2022
-
$6.73 M(-1561.7%)
$8.11 M(+465.7%)
Jun 2022
-
-$460.20 K(+80.9%)
$1.43 M(-40.1%)
Mar 2022
-
-$254.40 K(-112.1%)
$2.39 M(-89.5%)
Dec 2021
$22.86 M(+10.8%)
$2.10 M(+4045.1%)
$22.86 M(-0.2%)
Sep 2021
-
$50.60 K(-89.9%)
$22.90 M(-16.6%)
Jun 2021
-
$501.20 K(-97.5%)
$27.45 M(-33.1%)
Mar 2021
-
$20.21 M(+844.7%)
$41.03 M(+99.0%)
Dec 2020
$20.62 M(+21.8%)
$2.14 M(-53.5%)
$20.62 M(+8.4%)
Sep 2020
-
$4.60 M(-67.3%)
$19.02 M(-0.2%)
Jun 2020
-
$14.08 M(-7068.0%)
$19.05 M(+87.6%)
Mar 2020
-
-$202.10 K(-137.8%)
$10.16 M(-40.0%)
Dec 2019
$16.93 M(-5.8%)
$534.60 K(-88.5%)
$16.93 M(-0.6%)
Sep 2019
-
$4.64 M(-10.6%)
$17.03 M(-20.8%)
Jun 2019
-
$5.19 M(-21.0%)
$21.50 M(+27.9%)
Mar 2019
-
$6.57 M(+937.3%)
$16.81 M(-6.4%)
Dec 2018
$17.97 M(+813.4%)
$633.40 K(-93.0%)
$17.97 M(+2.3%)
Sep 2018
-
$9.11 M(+1719.5%)
$17.56 M(+100.7%)
Jun 2018
-
$500.60 K(-93.5%)
$8.75 M(-6.8%)
Mar 2018
-
$7.72 M(+3364.0%)
$9.39 M(+377.4%)
Dec 2017
$1.97 M(-92.2%)
$223.00 K(-25.5%)
$1.97 M(-85.5%)
Sep 2017
-
$299.30 K(-73.8%)
$13.52 M(+1.1%)
Jun 2017
-
$1.14 M(+279.8%)
$13.37 M(+9.1%)
Mar 2017
-
$301.10 K(-97.4%)
$12.25 M(-51.4%)
Dec 2016
$25.19 M(+102.4%)
$11.78 M(+7985.4%)
$25.19 M(+73.0%)
Sep 2016
-
$145.70 K(+471.4%)
$14.56 M(+1.9%)
Jun 2016
-
$25.50 K(-99.8%)
$14.29 M(-1.3%)
Mar 2016
-
$13.24 M(+1053.2%)
$14.48 M(+16.3%)
Dec 2015
$12.44 M(+116.9%)
$1.15 M(-1047.0%)
$12.44 M(+3.4%)
Sep 2015
-
-$121.20 K(-157.0%)
$12.03 M(-13.4%)
Jun 2015
-
$212.50 K(-98.1%)
$13.89 M(-1.0%)
Mar 2015
-
$11.20 M(+1427.6%)
$14.03 M(+144.5%)
Dec 2014
$5.74 M
$733.40 K(-57.8%)
$5.74 M(-6.3%)
Sep 2014
-
$1.74 M(+393.6%)
$6.12 M(+24.4%)
DateAnnualQuarterlyTTM
Jun 2014
-
$352.50 K(-87.9%)
$4.92 M(-16.8%)
Mar 2014
-
$2.91 M(+160.4%)
$5.91 M(+64.5%)
Dec 2013
$3.59 M(+45.3%)
$1.12 M(+107.9%)
$3.59 M(+19.9%)
Sep 2013
-
$537.90 K(-59.9%)
$3.00 M(-4.0%)
Jun 2013
-
$1.34 M(+125.8%)
$3.12 M(+20.7%)
Mar 2013
-
$594.70 K(+13.9%)
$2.59 M(+4.7%)
Dec 2012
$2.47 M(+24.8%)
$522.20 K(-21.4%)
$2.47 M(+26.8%)
Sep 2012
-
$664.20 K(-17.8%)
$1.95 M(+51.5%)
Jun 2012
-
$808.10 K(+68.6%)
$1.29 M(+168.2%)
Mar 2012
-
$479.30 K(>+9900.0%)
$480.40 K(+775.0%)
Dec 2011
$1.98 M(+3518.4%)
-
-
Aug 2011
-
$1100.00(>+9900.0%)
$54.90 K(0.0%)
Aug 2011
$54.80 K(+3123.5%)
-
-
May 2011
-
$0.00(-100.0%)
$54.90 K(0.0%)
Feb 2011
-
$400.00(-99.3%)
$54.90 K(-0.2%)
Nov 2010
-
$53.40 K(+4754.5%)
$55.00 K(+3135.3%)
Aug 2010
$1700.00(-71.2%)
$1100.00(>+9900.0%)
$1700.00(-5.6%)
May 2010
-
$0.00(-100.0%)
$1800.00(-58.1%)
Feb 2010
-
$500.00(+400.0%)
$4300.00(-25.9%)
Nov 2009
-
$100.00(-91.7%)
$5800.00(0.0%)
Aug 2009
$5900.00(>+9900.0%)
$1200.00(-52.0%)
$5800.00(+26.1%)
May 2009
-
$2500.00(+25.0%)
$4600.00(+119.0%)
Feb 2009
-
$2000.00(+1900.0%)
$2100.00(+2000.0%)
Nov 2008
-
$100.00(>+9900.0%)
$100.00(>+9900.0%)
Aug 2008
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
May 2008
-
$0.00(0.0%)
$5900.00(-1.7%)
Feb 2008
-
$0.00(0.0%)
$6000.00(-69.2%)
Nov 2007
-
$0.00(-100.0%)
$19.50 K(0.0%)
Aug 2007
$19.40 K(-62.8%)
$5900.00(+5800.0%)
$19.50 K(+43.4%)
May 2007
-
$100.00(-99.3%)
$13.60 K(+0.7%)
Feb 2007
-
$13.50 K(>+9900.0%)
$13.50 K(+419.2%)
Nov 2006
-
$0.00(0.0%)
$2600.00(-95.0%)
Aug 2006
$52.20 K(+1531.3%)
$0.00(0.0%)
$52.10 K(-0.2%)
May 2006
-
$0.00(-100.0%)
$52.20 K(-5.6%)
Feb 2006
-
$2600.00(-94.7%)
$55.30 K(+4.9%)
Nov 2005
-
$49.50 K(>+9900.0%)
$52.70 K(+1546.9%)
Aug 2005
$3200.00(>+9900.0%)
$100.00(-96.8%)
$3200.00(+3.2%)
May 2005
-
$3100.00(>+9900.0%)
$3100.00(>+9900.0%)
Feb 2005
-
$0.00(0.0%)
$0.00(0.0%)
Nov 2004
-
$0.00
$0.00
Aug 2004
$0.00
-
-

FAQ

  • What is VolitionRx Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for VolitionRx Limited?
  • What is VolitionRx Limited annual CFF year-on-year change?
  • What is VolitionRx Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for VolitionRx Limited?
  • What is VolitionRx Limited quarterly CFF year-on-year change?
  • What is VolitionRx Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for VolitionRx Limited?
  • What is VolitionRx Limited TTM CFF year-on-year change?

What is VolitionRx Limited annual cash flow from financing activities?

The current annual CFF of VNRX is $28.98 M

What is the all time high annual CFF for VolitionRx Limited?

VolitionRx Limited all-time high annual cash flow from financing activities is $28.98 M

What is VolitionRx Limited annual CFF year-on-year change?

Over the past year, VNRX annual cash flow from financing activities has changed by +$22.04 M (+317.74%)

What is VolitionRx Limited quarterly cash flow from financing activities?

The current quarterly CFF of VNRX is $5.60 M

What is the all time high quarterly CFF for VolitionRx Limited?

VolitionRx Limited all-time high quarterly cash flow from financing activities is $20.21 M

What is VolitionRx Limited quarterly CFF year-on-year change?

Over the past year, VNRX quarterly cash flow from financing activities has changed by +$1.83 M (+48.61%)

What is VolitionRx Limited TTM cash flow from financing activities?

The current TTM CFF of VNRX is $10.14 M

What is the all time high TTM CFF for VolitionRx Limited?

VolitionRx Limited all-time high TTM cash flow from financing activities is $41.03 M

What is VolitionRx Limited TTM CFF year-on-year change?

Over the past year, VNRX TTM cash flow from financing activities has changed by -$18.84 M (-65.02%)